Pharmaceutical Benefits Scheme gives better access to cystic fibrosis drug Trikafta
Starting July 1, more Australians with rarer cystic fibrosis mutations will gain access to Trikafta through the Pharmaceutical Benefits Scheme, ...
Starting July 1, more Australians with rarer cystic fibrosis mutations will gain access to Trikafta through the Pharmaceutical Benefits Scheme, ...
Summary23andMe will continue its DNA testing services following its acquisition by Regeneron Pharmaceuticals for $256 million after a bankruptcy auction. ...
Pharmaceutical companies are facing a potential hit as President Trump considers imposing tariffs on pharmaceutical imports, causing stock prices to ...
Afreximbank and Med Aditus signed an agreement to finance the preparation of feasibility studies for a US$40 million pharmaceutical manufacturing ...
Investing in pharmaceutical companies should consider their pipeline strength over current profits, as temporary sales of blockbuster drugs can impact ...
Prosper Africa’s Tech for Trade Alliance is partnering with USAID’s e-Trade Alliance, IBM Consulting, and NABP to launch Pulse by ...
Copyright © 2025 News Wave
News Wave is not responsible for the content of external sites.
Copyright © 2025 News Wave
News Wave is not responsible for the content of external sites.